-
Clinical analysis of patients with primary and secondary extranodal natural killer/T-cell lymphoma of central nervous system
Author: Li, Xingying; Yu, Hui; Fu, Xiaorui; Zhang, Lei; Li, Xin; Li, Ling; Wang, Xinhua; Sun, Zhenchang; Zhang, Xudong; Li, Zhaoming; Wu, Jingjing; Chang, Yu; Yan, Jiaqin; Zhou, Zhiyuan; Nan, Feifei; Wu, Xiaolong; Tian, Li; Zhang, Mingzhi
Journal: HEMATOLOGICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 267-274. DOI: 10.1002/hon.2894
-
Primary treatment and recent survival trends in patients with primary diffuse large B-cell lymphoma of central nervous system, 1995-2016: A population-based SEER analysis
Author: Chen, Cui; Sun, Peng; Sun, Xiao-Qing; Chen, Shao-Yong; Yang, Hang; Wang, Yu; Li, Zhi-Ming
Journal: HEMATOLOGICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 248-256. DOI: 10.1002/hon.2918
-
Improved method to stratify lymphoma patients with risk of secondary central nervous system involvement: A multicenter retrospective analysis
Author: Lang, Mingxiao; Feng, Youqin; Meng, Xiangrui; Zhao, Jing; Song, Zheng; Qian, Zhengzi; Qiu, Lihua; Zhou, Shiyong; Liu, Xianming; Li, Lanfang; Yang, Haiyan; Song, Yuqin; Li, Wei; Zhang, Huilai
Journal: HEMATOLOGICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 239-247. DOI: 10.1002/hon.2928
-
Review on natural killer/T-cell lymphoma
Author: He, Xiaohua; Gao, Yan; Li, Zhiming; Huang, Huiqiang
Journal: HEMATOLOGICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 221-229. DOI: 10.1002/hon.2944
-
Synergistic anticancer effect of a combination of chidamide and etoposide against NK/T cell lymphoma
Author: Song, Wenting; Chen, Zhan; Shi, Cunzhen; Gao, Yuyang; Feng, Xiaoyan; Li, Hongwen; Li, Zhaoming; Zhang, Mingzhi
Journal: HEMATOLOGICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 257-266. DOI: 10.1002/hon.2954
-
TAFRO syndrome with fatigue and abdominal distension as the first symptom: A case report
Author: Zhou, Bai; Tang, Chao; Chen, Guiyang; Jiang, Tiebin; Shi, Xiao; Wang, Fen
Journal: HEMATOLOGICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 285-290. DOI: 10.1002/hon.2962
-
Efficacy of programmed cell death 1 inhibitor maintenance therapy after combined treatment with programmed cell death 1 inhibitors and anti-CD19-chimeric antigen receptor T cells in patients with relapsed/refractory diffuse large B-cell lymphoma and high tumor burden
Author: Mu, Juan; Deng, Haobin; Lyu, Cuicui; Yuan, Jijun; Li, Qing; Wang, Jia; Jiang, Yanyu; Deng, Qi; Shen, Jichun
Journal: HEMATOLOGICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 275-284. DOI: 10.1002/hon.2981
-
Elevated serum IL-13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B-cell lymphoma
Author: Li, Xiao; Liu, Mengke; Shi, Qing; Fang, Ying; Fu, Di; Shen, Zhi-xiang; Yi, Hongmei; Wang, Li; Zhao, Weili
Journal: HEMATOLOGICAL ONCOLOGY. 2023; Vol. 41, Issue 2, pp. 230-238. DOI: 10.1002/hon.2993
